AMNEAL PHARMACT Cash Flow - Quarterly (NYSE:AMRX)

Add to My Stocks
$23.8 $0.34 (1.45%) AMRX stock closing price Sep 19, 2018 (Closing)
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
-198.44M-130.93M-469.28M-168.21M-118.84M-98.43M-472.03M-192.44M-13.1M-10.4M
Depreciation Depletion Amortization Cash-Flow49.47M17.97M109.44M85.37M53.96M25.75M88.34M63.1M36.41M15.72M
Net Increase (Decrease) in Assets Liabilities-119.52M18.04M-11.11M-18.07M22.65M20.69M-2.43M-22.25M-11.65M44.28M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net196.94M9.42M455.17M147.72M100.41M91.79M460.71M249.37M12.12M27.86M
Net Cash from (used by) Operating Activities
-71.55M-85.48M84.22M46.8M58.19M39.8M74.59M97.76M23.78M77.45M
Increase (Decrease) in Prop Plant And Equipment-36.6M-3.95M-17.63M-15.07M-18.64M-8.67M-48.04M-30.51M-19.16M-10.88M
Acquisition Disposition of Subsidiaires-324.32M--0.12M----585.8M-585.8M--
Increase (Decrease) in Investments---4.22M----4.75M---
Other Cash Inflow (Outflow) from Investment Activities-17.75M12.3M11.85M11.85M-11.5M11.5M11.5M-3.5M
Net Cash from (used by) Investment Activities
-360.92M13.79M-9.68M-2.69M-6.26M-8.15M-627.09M-604.81M-7.66M-14.38M
Issuance (Purchase) of Equity Shares1.98M-1.37M---9.23M9.13M9.17M7.66M
Issuance (Repayment) of Debt Securities721.71M-5M-70M-65M-60M-55M395M400M--
Increase (Decrease) in Bank & Other Borrowings-89.84M---------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-209.85M-0.98M-5.04M-3.48M-2.7M-1.26M-12.45M-11.36M--
Net Cash from (used by) Financing Activities
424M-5.47M-73.67M-67.63M-62.11M-56.09M391.78M397.77M9.71M8.1M
Effect of Exchange Rate Changes on Cash-0.85M-0.42M-1.04M1.45M1.56M-1.04M--
Net Change in Cash & Cash Equivalents
-9.33M-77.58M1.64M-22.47M-8.73M-22.88M-160.21M-108.22M26.49M71.82M
Cash & Equivalents at Beginning of Year77.92M180.13M340.35M214.87M184.61M142.16M104.41M91.79M31.77M69.27M
Cash & Equivalents at Year End68.59M104.19M181.77M157.65M171.39M157.25M180.13M232.12M366.84M412.17M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Key Financial Ratios For AMNEAL PHARMACT Cash Flow

Quarterly Cash Flow Statements For AMNEAL PHARMACT Peers

Catalent cash flow, Lipocine cash flow, Sage Therapeutics cash flow